Related Experiment Video
Updated: Apr 30, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges
Nathan E Goldstein1, Jill Kalman2, Jean S Kutner3
1Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA.
Insights
This study faced challenges in implementing a trial to improve discussions about implantable cardioverter defibrillators (ICDs) for advanced heart failure patients. Solutions were developed to overcome barriers related to palliative care, patient identification, and evolving treatment options.
Area of Science:
- Cardiology
- Palliative Care
- Clinical Trials
Background:
- Advanced heart failure (HF) patients with implantable cardioverter defibrillators (ICDs) require sensitive communication regarding deactivation.
- Improving patient-provider communication is crucial for end-of-life care in advanced HF.
Purpose of the Study:
- To describe the implementation challenges and solutions for a multicenter trial (Working to Improve Discussions About Defibrillator Management) focused on ICD deactivation conversations.
- To assess the impact of an intervention on increasing ICD deactivation discussions, actual deactivations, and caregiver psychological outcomes.
- To identify and address barriers in conducting research with advanced HF patients and their caregivers.
Main Methods:
- A multicenter, randomized trial comparing usual care to an intervention for HF clinicians.
- The intervention included educational sessions, clinician reminders, and individualized feedback.
- Patients with advanced HF and their caregivers were enrolled and surveyed to evaluate communication improvements.
Main Results:
- Implementation barriers included institutional review board concerns regarding palliative care, difficulties defining high-risk patient criteria, and adapting to changing ventricular assist device and transplant eligibility.
- Novel solutions were developed to overcome these identified barriers.
- The study provides insights into enhancing the conduct of future research in advanced illness care.
Conclusions:
- Conducting trials on ICD deactivation in advanced HF presents unique challenges.
- Adaptability and innovative problem-solving are essential for successful implementation of such studies.
- This research offers valuable lessons for future trials aimed at improving end-of-life care for patients with advanced cardiovascular conditions.
Abstract:
We report the challenges of the Working to Improve Discussions About Defibrillator Management trial, our novel, multicenter trial aimed at improving communication between cardiology clinicians and their patients with advanced heart failure (HF) who have implantable cardioverter defibrillators (ICDs). The study objectives are (1) to increase ICD deactivation conversations, (2) to increase the number of ICDs deactivated, and (3) to improve psychological outcomes in bereaved caregivers. The unit of randomization is the hospital, the intervention is aimed at HF clinicians, and the patient and caregiver are the units of analysis. Three hospitals were randomized to usual care and three to intervention. The intervention consists of an interactive educational session, clinician reminders, and individualized feedback. We enroll patients with advanced HF and their caregivers, and then we regularly survey them to evaluate whether the intervention has improved communication between them and their HF providers. We encountered three implementation barriers. First, there were institutional review board concerns at two sites because of the palliative nature of the study. Second, we had difficulty in creating entry criteria that accurately identified an HF population at high risk of dying. Third, we had to adapt our entry criteria to the changing landscape of ventricular assist devices and cardiac transplant eligibility. Here we present our novel solutions to the difficulties we encountered. Our work has the ability to enhance conduct of future studies focusing on improving care for patients with advanced illness.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation